Sara E. Surguta
Budapest, BU 1037, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance.
Journal: Cancers
Published: May 05, 2026
Neuropilin-1-Targeted Cell-Penetrating Tandem Peptide-Drug Conjugate Exhibits Potent In Vivo Antiglioma and Antiangiogenic Activity.
Journal: Journal of medicinal chemistry
Published: April 20, 2026
Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma.
Journal: International journal of molecular sciences
Published: May 21, 2025
Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma.
Journal: Scientific reports
Published: April 07, 2025
Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 11, 2024
Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade.
Journal: Cancers
Published: March 25, 2024
Lectin-Based Immunophenotyping and Whole Proteomic Profiling of CT-26 Colon Carcinoma Murine Model.
Journal: International journal of molecular sciences
Published: February 23, 2024
Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma.
Journal: Scientific reports
Published: February 20, 2024
Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection.
Journal: Bioconjugate chemistry
Published: August 22, 2023
Consequences of extracellular alterations of EGFR on cetuximab therapy in HNSCC
Journal: Magyar onkologia
Published: April 18, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026